Pfizer to put India on global launch radar
Pfizer Ltd. is considering aligning its business with its parent company, Pfizer Inc. Typically, the time lag between product launches in the global and the Indian markets varies between six months and two years.
Pfizer India is trying to bring this time lag down between six months and one year, he hinted. Meanwhile, the company would be concentrating more on organic growth.
The company expects to record double-digit growth in the financial year ending November 2006 against 7 per cent growth of the domestic pharmaceutical market.
The company is currently conducting in India around 34 clinical trials, of which 24 are for the global market, informed Shoibal Mukherjee, senior director, medical, Pfizer.
Earlier this year, Pfizer launched Vfend in India, one year after its launch in the global market.
But the case with Viagra, popular 'blue pill' for treating erectile dysfunction (in men), is far worse.
The drug was launched in the Indian market on December 26, 2005 seven years after it was launched in the international market.
Viagra would be launched in 30 cities. "We would be looking at 10-15 per cent share of Rs 80 crore (Rs 800 million) Indian market, within the next one-two years," Handa added.
The product would be imported from France. Currently, the company has no plan for manufacturing Viagra at its Indian unit.